Dr. Hang Zhou studied Biotechnology and received his PhD in Chemical Engineering from Massachusetts Institute of Technology. He has more than 10 years of experience in cell culture process development, in particular continuous processing. At WuXi Biologics Hang leads a team in continuous cell culture process development for biologics, from scale-down model to pilot and GMP production. His team successfully overcame multiple challenges accompanied with intensified perfusion culture for extended duration, while achieving high productivity and desirable product quality. Prior to joining WuXi Biologics, Dr. Zhou worked for Commercial Cell Culture Development at SANOFI GENZYME and led efforts in the next-generation perfusion platform development, focusing on high cell density and productivity cell culture process development.